Skip to main content

Vicente Bebia Conesa

Medical Degree (Universidad de Murcia). Specialist in Gynecology and Obstetrics (Hospital 12 de Octubre, 2018). Gynecologic Oncologist (Vall d'Hebron, endorsed by ESGO).

Institutions of which they are part

Main researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca
Doctor
Ginecologia Oncològica i Patologia del Tracte Genital Inferior
Children's Hospital and Woman's Hospital

Vicente Bebia Conesa

Institutions of which they are part

Main researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca
Doctor
Ginecologia Oncològica i Patologia del Tracte Genital Inferior
Children's Hospital and Woman's Hospital

Medical Degree (Universidad de Murcia). Specialist in Gynecology and Obstetrics (Hospital 12 de Octubre, 2018). Gynecologic Oncologist (Vall d'Hebron, endorsed by ESGO).

I was born in Cartagena (Spain) in 1989. I completed my Medical Degree at Universidad de Murcia (Class 2007-2013). Via MIR, I finished the residency program in Obstetrics and Gynecology at Hospital 12 de Octubre (Madrid), where my interest in the surgical treatment of gynecological neoplasms began. After a brief period as a specialist at Hospital 12 de Octubre, I moved to Barcelona to pursue the Fellowship program in Gynecological Oncology at Vall d'Hebron. Currently, and after obtaining the Gynecologic Oncologist diploma endorsed by the European Society of Gynecology Oncology (ESGO), I work at the Gynecology Oncology Unit of Vall d'Hebron.
Along with the daily surgical activity, I do research as a member of the Gynecology Biomedical Research Group at VHIR. My main interests lie in the management and diagnosis of lymph node involvement in gynecological neoplasms (both clinically and surgically), as well as searching for new surgical methods for the treatment of tumors of gynecological origin.

Projects

Búsqueda de firmas proteómicas y dianas terapéuticas en el cáncer de ovario seroso de alto grado avanzado resistente a platino

IP: Antonio Gil Moreno
Collaborators: Vicente Bebia Conesa, Francesc Xavier Serra Marin, Marta Rebull Santamaria, Martina Angeles Fite, Ana Luzarraga Aznar, Melissa Bradbury Lobato, Beatriz Villafranca Magdalena, Melek Denizli, Lourdes Elena Salazar Huayna, Giulio Bonaldo, Valeria Tubita
Funding agency: Instituto de Salud Carlos III
Funding: 196250
Reference: PI24/01509
Duration: 01/01/2025 - 31/12/2027

ScreenEC, validació d'una eina de triatge no invasiu en càncer d'endometri

IP: Eva Colas Ortega
Collaborators: Vicente Bebia Conesa, Francesc Xavier Serra Marin, Josep Castellví Vives, Silvia Cabrera Diaz, Antonio Gil Moreno, Marta Rebull Santamaria, Ana Luzarraga Aznar, Irene De la Calle Fuentes, Lourdes Elena Salazar Huayna
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 99946
Reference: SLT036/24/000059
Duration: 21/12/2024 - 31/12/2026

Telemedicine-guided Patients Reported Outcome Measures (PROMs): side efects screening and early intervention to impact in quality of life of gynaecological cancer patients.

IP: Vicente Bebia Conesa
Collaborators: Maria Asuncion Perez Benavente, Francesc Xavier Serra Marin, Antonio Gil Moreno, Martina Angeles Fite, Ana Luzarraga Aznar, Irene De la Calle Fuentes, Melissa Bradbury Lobato, Melek Denizli, Giulio Bonaldo
Funding agency: Fundació La Marató de TV3
Funding: 96737.5
Reference: 202403-30
Duration: 28/02/2025 - 27/02/2028

Desarrollo de CEMARK-Px, un método in vitro para el diagnóstico objetivo y preciso del tipo y grado histológico del cáncer de endometrio en fluido uterino

IP: Eva Colas Ortega
Collaborators: Vicente Bebia Conesa, Silvia Cabrera Diaz, Antonio Gil Moreno, Marta Rebull Santamaria, Ana Luzarraga Aznar, Irene De la Calle Fuentes, Melek Denizli, Lourdes Elena Salazar Huayna
Funding agency: Instituto de Salud Carlos III
Funding: 278300
Reference: DTS23/00091
Duration: 01/01/2024 - 31/12/2026

Related news

Researchers from the centre took part in international debates on AI in healthcare, spin-offs emerging from research were presented, and several initiatives linked to VHIR received recognition in the field of entrepreneurship.

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Related professionals

Almudena Felipe Montiel

Almudena Felipe Montiel

Predoctoral researcher
Pneumology
Read more
Baptiste Milot

Baptiste Milot

Research technician
Pharmacokinetic Nanoparticles
Read more
Laura Gisbert  Gustemps

Laura Gisbert Gustemps

Main researcher
Psychiatry, Mental Health and Addictions
Read more
Chiara Piccinini

Chiara Piccinini

Predoctoral researcher
Gene Therapy at Nervous System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.